Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

1.

53BP1 expression is a modifier of the prognostic value of lymph node ratio and CA 19-9 in pancreatic adenocarcinoma.

Ausborn NL, Wang T, Wentz SC, Washington MK, Merchant NB, Zhao Z, Shyr Y, Chakravarthy AB, Xia F.

BMC Cancer. 2013 Mar 26;13:155. doi: 10.1186/1471-2407-13-155.

PMID:
23530749
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma.

La Torre M, Nigri G, Cavallini M, Mercantini P, Ziparo V, Ramacciato G.

Ann Surg Oncol. 2012 Sep;19(9):2917-23. doi: 10.1245/s10434-012-2348-9. Epub 2012 Apr 10.

PMID:
22488099
[PubMed - indexed for MEDLINE]
3.

High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer.

Chen HT, Cai QC, Zheng JM, Man XH, Jiang H, Song B, Jin G, Zhu W, Li ZS.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S464-74. doi: 10.1245/s10434-011-1968-9. Epub 2011 Aug 6.

PMID:
21822553
[PubMed - indexed for MEDLINE]
4.

The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.

Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT, Makowiec F.

J Gastrointest Surg. 2009 Jul;13(7):1337-44. doi: 10.1007/s11605-009-0919-2. Epub 2009 May 6.

PMID:
19418101
[PubMed - indexed for MEDLINE]
5.

Lymph node ratio is an independent prognostic factor after resection of periampullary malignancies: data from a tertiary referral center in the middle East.

Shamseddine AI, Mukherji D, Melki C, Elias E, Eloubeidi M, Dimassi H, Khalife M, Abou-Alfa G, O'Reilly E, Faraj W.

Am J Clin Oncol. 2014 Feb;37(1):13-8. doi: 10.1097/COC.0b013e31826b9c74.

PMID:
23111358
[PubMed - indexed for MEDLINE]
6.

Redefining the R1 resection for pancreatic ductal adenocarcinoma: tumour lymph nodal burden and lymph node ratio are the only prognostic factors associated with survival.

John BJ, Naik P, Ironside A, Davidson BR, Fusai G, Gillmore R, Watkins J, Rahman SH.

HPB (Oxford). 2013 Sep;15(9):674-80. doi: 10.1111/hpb.12019. Epub 2013 Jan 14.

PMID:
23458477
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Number of lymph nodes evaluated: prognostic value in pancreatic adenocarcinoma.

Huebner M, Kendrick M, Reid-Lombardo KM, Que F, Therneau T, Qin R, Donohue J, Nagorney D, Farnell M, Sarr M.

J Gastrointest Surg. 2012 May;16(5):920-6. doi: 10.1007/s11605-012-1853-2. Epub 2012 Mar 16.

PMID:
22421988
[PubMed - indexed for MEDLINE]
8.

Prognostic value of the lymph node ratio after resection of periampullary carcinomas.

Farid SG, Falk GA, Joyce D, Chalikonda S, Walsh RM, Smith AM, Morris-Stiff G.

HPB (Oxford). 2014 Jun;16(6):582-91. doi: 10.1111/j.1477-2574.2012.00614.x. Epub 2012 Nov 19.

PMID:
23777362
[PubMed - indexed for MEDLINE]
9.

Lymph node ratio versus number of affected lymph nodes as predictors of survival for resected pancreatic adenocarcinoma.

Bhatti I, Peacock O, Awan AK, Semeraro D, Larvin M, Hall RI.

World J Surg. 2010 Apr;34(4):768-75. doi: 10.1007/s00268-009-0336-4.

PMID:
20052471
[PubMed - indexed for MEDLINE]
10.

Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis.

La Torre M, Cavallini M, Ramacciato G, Cosenza G, Rossi Del Monte S, Nigri G, Ferri M, Mercantini P, Ziparo V.

J Surg Oncol. 2011 Nov 1;104(6):629-33. doi: 10.1002/jso.22013. Epub 2011 Jun 28.

PMID:
21713779
[PubMed - indexed for MEDLINE]
11.

The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma.

Berger AC, Watson JC, Ross EA, Hoffman JP.

Am Surg. 2004 Mar;70(3):235-40; discussion 240.

PMID:
15055847
[PubMed - indexed for MEDLINE]
12.

The relationship between tumor inflammatory cell infiltrate and outcome in patients with pancreatic ductal adenocarcinoma.

Jamieson NB, Mohamed M, Oien KA, Foulis AK, Dickson EJ, Imrie CW, Carter CR, McKay CJ, McMillan DC.

Ann Surg Oncol. 2012 Oct;19(11):3581-90. doi: 10.1245/s10434-012-2370-y. Epub 2012 May 4.

PMID:
22555345
[PubMed - indexed for MEDLINE]
13.

Prognostic relevance of number and ratio of metastatic lymph nodes in resected pancreatic, ampullary, and distal bile duct carcinomas.

Pomianowska E, Westgaard A, Mathisen Ø, Clausen OP, Gladhaug IP.

Ann Surg Oncol. 2013 Jan;20(1):233-41. doi: 10.1245/s10434-012-2592-z. Epub 2012 Aug 15.

PMID:
22893118
[PubMed - indexed for MEDLINE]
14.

Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.

Slidell MB, Chang DC, Cameron JL, Wolfgang C, Herman JM, Schulick RD, Choti MA, Pawlik TM.

Ann Surg Oncol. 2008 Jan;15(1):165-74. Epub 2007 Sep 26.

PMID:
17896141
[PubMed - indexed for MEDLINE]
15.

Preoperative CA19-9 levels and lymph node ratio are independent predictors of survival in patients with resected pancreatic ductal adenocarcinoma.

Smith RA, Bosonnet L, Ghaneh P, Raraty M, Sutton R, Campbell F, Neoptolemos JP.

Dig Surg. 2008;25(3):226-32. doi: 10.1159/000140961. Epub 2008 Jun 24.

PMID:
18577869
[PubMed - indexed for MEDLINE]
16.

Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.

Distler M, Pilarsky E, Kersting S, Grützmann R.

Int J Surg. 2013;11(10):1067-72. doi: 10.1016/j.ijsu.2013.10.005. Epub 2013 Oct 23.

PMID:
24161419
[PubMed - indexed for MEDLINE]
17.

The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.

Qiu C, Dong W, Su B, Liu Q, Du J.

J Thorac Oncol. 2013 Apr;8(4):429-35. doi: 10.1097/JTO.0b013e3182829c16.

PMID:
23486264
[PubMed - indexed for MEDLINE]
18.

Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study.

Dong Q, Yang XH, Zhang Y, Jing W, Zheng LQ, Liu YP, Qu XJ.

World J Surg Oncol. 2014 Jun 2;12:171. doi: 10.1186/1477-7819-12-171.

PMID:
24890327
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

[Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].

Li Y, Sun BS, Zhang ZF, Zhang LM, Wang CL.

Zhonghua Yi Xue Za Zhi. 2011 Jun 28;91(24):1682-6. Chinese.

PMID:
21914316
[PubMed - indexed for MEDLINE]
20.

Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.

Pawlik TM, Gleisner AL, Cameron JL, Winter JM, Assumpcao L, Lillemoe KD, Wolfgang C, Hruban RH, Schulick RD, Yeo CJ, Choti MA.

Surgery. 2007 May;141(5):610-8. Epub 2007 Mar 23.

PMID:
17462460
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk